SK
Sky Century Investment, Inc.
SKYI · OTC
$0.10 +20.88% (+$0.02)
1M -3.30%
Market Cap $123.4K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.15
55.1% upside
Current Price
$0.097
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKYI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.98x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 19.07%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 52.92%
Net margin 49.48%
Op. margin 49.48%
Quality
75 /100
Excellent ROIC 77.64%
ROA 48.57%
Asset turnover 0.98x
Debt
0 /100
High Current ratio 0.04x
Debt/Equity N/A
Int. coverage N/A
Stability
32 /100
Unstable Beta 1.87x
Rev. volatility 103.58%
EPS volatility 12.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKYI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nataliia Petranetska
Employees
1
Headquarters
Las Vegas